You searched for Humanized antibody - Page 35 of 45

News and Trends 7 Sep 2022

Could COVID vaccine boosters become obsolete?

…the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain…

September 7, 2022 - 5 minutesmins - By Jim Cornall

argenx efgartigimod treatment autoimmune disease myasthenia gravis

News and Trends 21 Dec 2021

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

…marketed as Vyvgart, is an antibody fragment drug for use in adults with generalized myasthenia gravis. The FDA’s decision represents the first successful drug approval for argenx. According to Evaluate…

December 21, 2021 - 4 minutesmins - By Anita Chakraverty

More News! 17 Jul 2024

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

…“The majority of tau pathology, characterized by neurofibrillary tangles in Alzheimer’s disease is intracellular within neurons. This is hard to access with antibody-based treatment approaches. The development of OGA-inhibiting therapies,…

July 17, 2024 - 10 minutesmins - By Jules Adam

News and Trends 13 Mar 2023

New therapy for prevention and treatment of COVID-19

…vivo model. ExeVir Bio’s COVID-19 pipeline includes XVR012, a combination product of the S2-targeting single-domain antibody-based XVR013 reported in the pre-print paper, and XVR014, a bispecific single-domain-based antibody construct that…

March 13, 2023 - 4 minutesmins - By Jim Cornall

In Depth 13 Dec 2024

Is China the future of biotech?

…Chinese companies were biologics. The report notes that the number of antibody drug conjugate (ADC), bispecific antibody, and CAR-T pipelines has increased by seven, five, and four times, respectively. The…

December 13, 2024 - 12 minutesmins - By Jules Adam

News and Trends 23 May 2016

To Be – or Not To Be, a Virtual Biotech?

…one asset, with fixed costs well below 20% of their burn rate. For example, since its founding, the biotech XO1 (Hatfield, UK) operated virtually, working on a single anti-thrombin antibody…

May 23, 2016 - 5 minutesmins - By Dani Bancroft

News and Trends 6 Jun 2023

Shasqi using click chemistry to target cancer

…antibody drug conjugates,” said Mukul Agarwal, chief business officer at Shasqi. “The reliance on chemistry, not biology for drug activation, allows for the use of small molecules, peptides, and antibody…

June 6, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 7 Sep 2022

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

…in a separate biology cohort. About OR2805 OR2805 is a fully human antibody discovered using B cells derived from an elite responder to checkpoint inhibitor (CPI) therapy. This antibody binds…

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 24 Mar 2025

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

…antibody-drug conjugates (ADCs), which are composed of a monoclonal antibody, a cytotoxic drug – typically a chemotherapy – and a linker. But unlike ADCs, which deliver the drug specifically to…

March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 12 Aug 2022

argenx secures European Commission approval for generalized myasthenia gravis treatment

…generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive. The approval is applicable to all 27 European Union (EU) Member States plus Iceland, Norway and Liechtenstein. argenx said…

August 12, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 16 May 2023

LabGenius looks to create molecules with huge increase in tumor killing ability

LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering and Biotherapeutics (PEGS) annual meeting. The data were from LabGenius’…

May 16, 2023 - 3 minutesmins - By Jim Cornall

KBI Biopharma microbial CLD 16JUL2024 article labiotech main illustration

How a microbial expression update is driving biotech innovation

…to prepare for future applications, including antibody fragments and therapeutic peptides. While microbial protein production systems present cost-efficient alternatives to insect or mammalian cells, the commonly used E. coli strains…

July 16, 2024 - 7 minutesmins - By Ute Boronowsky

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Could COVID vaccine boosters become obsolete?

Argenx’s Potential Blockbuster Gets FDA Nod for Autoimmune Disease

Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it

New therapy for prevention and treatment of COVID-19

Is China the future of biotech?

To Be – or Not To Be, a Virtual Biotech?

Shasqi using click chemistry to target cancer

OncoResponse and Regeneron to evaluate drug combo for patients with advanced cancer

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

argenx secures European Commission approval for generalized myasthenia gravis treatment

LabGenius looks to create molecules with huge increase in tumor killing ability

How a microbial expression update is driving biotech innovation

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!